Brief: Petros Pharmaceuticals Announces Second Quarter Financial Results
17/08/2021 14:26
Aug 17 (Reuters) - Petros Pharmaceuticals Inc PTPI.O :
* PETROS PHARMACEUTICALS ANNOUNCES SECOND QUARTER FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE; REPORTS A 123% INCREASE
IN YEAR OVER YEAR QUARTERLY STENDRA® (AVANAFIL) NET SALES
* Q2 SALES $2.5 MILLION
* CASH TOTALED $11.0 MILLION AT JUNE 30, 2021, COMPARED TO
$17.1
MILLION AT DECEMBER 31, 2020
Source text for Eikon: ID:nPn9gHTqFa
Further company coverage: PTPI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Petros Pharmaceuticals
See all newsBrief: Petros Pharmaceuticals Assigns All Assets To Pt Liquidation, For Benefit Of Creditors
Brief: Petros Pharmaceuticals’ STENDRA Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance
Brief: Petros Pharmaceuticals Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: Petros Pharmaceuticals Expands Online Distribution For Prescription STENDRA(R) Through New Agreement With Lemonaid Health
Brief: Petros Pharma Announces Partnership with Idea Evolver for Rx-to-OTC Switches & Digital Launch Solutions